CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270604595
- Phone
- 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-31 | PERRY GREGORY D Director | Returned to the company · Stock Option (right to buy) | −420 | 0 | ||
| 2023-05-31 | PERRY GREGORY D Director | Returned to the company · Stock Option (right to buy) | −800 | 0 | ||
| 2023-05-31 | Myers C. Daniel Director | Grant or award | +1,640 | 1,640 | ||
| 2023-05-31 | Myers C. Daniel Director | Returned to the company · Stock Option (right to buy) | −840 | 0 | ||
| 2023-05-31 | Myers C. Daniel Director | Returned to the company · Stock Option (right to buy) | −800 | 0 | ||
| 2023-05-31 | KOVEN ANDREW I Director | Grant or award | +2,197 | 3,257 | ||
| 2023-05-31 | KOVEN ANDREW I Director | Returned to the company · Stock Option (right to buy) | −518 | 0 | ||
| 2023-05-31 | KOVEN ANDREW I Director | Returned to the company · Stock Option (right to buy) | −259 | 0 | ||
| 2023-05-31 | KOVEN ANDREW I Director | Returned to the company · Stock Option (right to buy) | −420 | 0 | ||
| 2023-05-31 | KOVEN ANDREW I Director | Returned to the company · Stock Option (right to buy) | −1,000 | 0 | ||
| 2023-05-31 | Blumenkranz Mark S. Director | Grant or award | +1,640 | 6,807 | ||
| 2023-05-31 | Blumenkranz Mark S. Director | Returned to the company · Stock Option (right to buy) | −840 | 0 | ||
| 2023-05-31 | Blumenkranz Mark S. Director | Returned to the company · Stock Option (right to buy) | −800 | 0 | ||
| 2023-05-31 | Kharabi Darius CHIEF BUSINESS OFFICER | Grant or award | +2,648 | 25,055 | ||
| 2023-05-31 | Kharabi Darius CHIEF BUSINESS OFFICER | Returned to the company · Stock Option (right to buy) | −2,000 | 0 | ||
| 2023-05-31 | Kharabi Darius CHIEF BUSINESS OFFICER | Returned to the company · Stock Option (right to buy) | −648 | 0 | ||
| 2023-05-31 | Trachtenberg Eric SEE REMARKS | Grant or award | +15,639 | 27,134 | ||
| 2023-05-31 | Trachtenberg Eric SEE REMARKS | Returned to the company · Stock Option (right to buy) | −3,000 | 0 | ||
| 2023-05-31 | Trachtenberg Eric SEE REMARKS | Returned to the company · Stock Option (right to buy) | −2,721 | 0 | ||
| 2023-05-31 | Trachtenberg Eric SEE REMARKS | Returned to the company · Stock Option (right to buy) | −1,999 | 0 |
Page 8 of 12 · 236 trades